BOSTON — Stem cell therapies for retinal diseases come with advantages and disadvantages, according to a speaker at the American Society of Cataract and Refractive Surgery meeting.
Rajesh C. Rao, MD, ABO, said stem cells therapy has gotten a lot of attention, but so far, progress has been slow.
“There are many trials that have happened essentially over the last 10 years,” he said. “We’re really limited by the size of these trials. Many of them have not made it past phase 2.”
Researchers have been able to identify some (Read more...)